Discovery and Evaluation of Dual CDK1 and CDK2 InhibitorsMarc Payton(Amgen (United States)), Steve CoatsCancer ResearchApril 15, 200610.1158/0008-5472.can-05-2507Cited by 84SaveCiteExport RISWatch citationsRelated Paperslnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin|Nature|1994|896